CTU: An Open-label, Single-arm, Multi-center Phase 1/IIA Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SHR-A1904-l-104 in Patients with Advanced Solid Tumors Expressing Claudin 18.2

  • Park, John (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Chester, Catherine (Clinical Trial Unit Staff)
  • TAIDI, Gina (Clinical Trial Unit Staff)
  • Contacos, Christine (Clinical Trial Unit Staff)
  • Martin, Lewis (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleSHR-A1904-I-104
StatusActive
Effective start/end date17/01/2426/10/28